AzTrials
AzTrials

Subthreshold DepressionNCT06517121

tDCS in People With Subthreshold Depression

A study testing Personalized Experimental Transcranial Direct Current Stimulation (tDCS) and Conventional Experimental Transcranial Direct Current Stimulation (tDCS) in people with Subthreshold Depression, run by Education University of Hong Kong at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

This study evaluates the effects of multi-session transcranial direct current stimulation on loneliness, mood and depressiveness in people with subthreshold depression. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Subthreshold Depression
What is being tested?
Personalized Experimental Transcranial Direct Current Stimulation (tDCS) and Conventional Experimental Transcranial Direct Current Stimulation (tDCS)
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
204 participants
Where
1 siteHong Kong
Study dates
16 Jan 2026to Jan 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • No histories of learning impairment, major psychiatric disorders including Major Depressive Disorder or neurological disorders
  • At least primary school education
  • Subthreshold depression

Who cannot join

  • On medication or treatments within 2 weeks prior to the beginning of the study that would affect the individual's brain, cognitive and affective functions

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nichol ML Wong, PhD contact

852-29487431

nmlwong@eduhk.hk

Hong Kong1 site, 1 recruiting
  • The Education University of Hong Kong

    Hong Kong

    Nichol ML Wong, PhD, 852-29487431, nmlwong@eduhk.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: Personalised Transcranial Direct Current Stimulation to Reduce Daily Loneliness in People With Subthreshold Depression

This study evaluates the effects of multi-session transcranial direct current stimulation on loneliness, mood and depressiveness in people with subthreshold depression.

Read the detailed description

Depression-prone individuals will be invited and allocated to three groups, either the personalised transcranial direct current stimulation (tDCS) group, the conventional tDCS group, or the sham control group. After screening and at baseline prior to the tDCS sessions, participants will complete tests and questionnaires on depression symptoms, loneliness and mood. Eligible participants will also be invited to receive functional magnetic resonance imaging (MRI) in a 3-Tesla MRI scanner. There will be a maximum of 10 sessions to be completed after the screening and baseline measures. For both personalised tDCS group and the conventional tDCS group, tDCS with 2 milliampere (mA) intensity will be delivered for 20 minutes in each session. For sham control group, the protocol will be similar, except that the stimulation only happens in the first 30 seconds in each session. Especially for participants allocated to the personalised tDCS group, the stimulation site for each individual in this group may vary, depending on their brain activations and connectivity. The anodal stimulation sites for participants allocated to the conventional tDCS group and the sham control group will be F3 within the left DLPFC. Immediately after and also 3-months after completing all the tDCS sessions, participants will be invited to complete again tests and questionnaires on depressive symptoms in addition to loneliness and mood. Eligible participants will also be invited to receive functional MRI scanning in the 3T MRI scanner again. Participants will also be prompted to self-report daily their loneliness and mood levels throughout the study.

Being tested
Personalized Experimental Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS), Conventional Experimental Transcranial Direct Current Stimulation (tDCS)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personalized Experimental Transcranial Direct Current Stimulation (tDCS)Device

    This study will deliver tDCS sessions for a maximum of ten sessions in two weeks' time. Participants will receive 20 minutes of active stimulation with a 2mA intensity over personalized brain regions based on the particular neural correlates of socio-affective processing.

  • Sham Transcranial Direct Current Stimulation (tDCS)Device

    This study will deliver tDCS sessions for a maximum of ten sessions in two weeks' time. Participants assigned to the sham control group will only receive 30 seconds of active stimulation.

  • Conventional Experimental Transcranial Direct Current Stimulation (tDCS)Device

    This study will deliver tDCS sessions for a maximum of ten sessions in two weeks' time. Participants will receive 20 minutes of active stimulation with a 2mA intensity with anode placed over F3.

Study groups in NCT06517121
Study groupRoleWhat they receive
Personalised tDCS groupExperimentalParticipants who are assigned to the personalised group will receive anodal tDCS over a individualized stimulation site.
Receives: Device: Personalized Experimental Transcranial Direct Current Stimulation (tDCS)
Conventional tDCS groupExperimentalParticipants who are assigned to the Conventional group will receive anodal tDCS over F3.
Receives: Device: Conventional Experimental Transcranial Direct Current Stimulation (tDCS)
Sham control groupSham comparatorParticipants who are assigned to the Conventional group will receive sham tDCS. The active stimulation will be delivered for the first 30 seconds only.
Receives: Device: Sham Transcranial Direct Current Stimulation (tDCS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in self-reported loneliness

    Loneliness is assessed based on the University of California, Los Angeles (UCLA) loneliness scale and single item, in which higher scores indicate greater degrees of loneliness.

    Measured: From baseline to after the last tDCS session; from baseline to 3 months after the last tDCS session

Secondary outcomes (4)
  1. Changes in depressive symptoms

    Depressive symptoms are assessed based on the Hospital Anxiety and Depression Scale, a 14-item scale assessing severity of depressive and anxiety symptom (score range 0 - 21 for both subscale), with a higher scores indicating higher severity

    Measured: From baseline to after the last tDCS session; from baseline to 3 months after the last tDCS session

  2. Changes in anxiety symptoms

    Anxiety symptoms are assessed based on the Hospital Anxiety and Depression Scale, a 14-item scale assessing severity of depressive and anxiety symptom (score range 0 - 21 for both subscale), with a higher scores indicating higher severity

    Measured: From baseline to after the last tDCS session; from baseline to 3 months after the last tDCS session

  3. Changes in self-reported mood

    Mood is assessed based on the Chinese Affect Scale, a 20-item 5-point Likert scale where participants rate the degree to which they currently feel the listed affects (scoring for each item: 0 = no at all; 4 = very).

    Measured: From baseline to after the last tDCS session; from baseline to 3 months after the last tDCS session

  4. Changes in brain activation and connectivity

    Neural activities and connectivity in Ventral Attention Network, Frontoparietal Network, and Default Mode Network are assessed by functional MRI

    Measured: From baseline to after the last tDCS session; from baseline to 3 months after the last tDCS session

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2024
  2. Study start16 Jan 2026
  3. Primary completionJan 2027 (estimated)
  4. Study completionJan 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06517121
Sponsor's protocol ID
2023-2024-0048
Status last verified
Jan 2026
First submitted
11 Jul 2024
Last updated
2 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in